TCTMD Spotlight

EuroPCR

Latest NewsSubscribe to Latest News

Friday, May 25, 2012 | Source: Journal of the American College of Cardiology

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

By L.A. McKeown

Patients with acute coronary syndromes (ACS) who undergo coronary artery bypass graft (CABG) surgery have lower mortality if they have been receiving…

Thursday, May 24, 2012 | Source: Journal of the American Medical Association

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

By Yael Maxwell

Cracking, peeling, and other damage to polymer surfaces can be seen following delivery balloon expansion in all 4 drug eluting stents (DES) currently…

Wednesday, May 23, 2012 | Source: Radiology

Contrast-Enhanced Ultrasound Viable Alternative to CTA for EVAR Follow-up

By Alison Palkhivala

Second generation contrast enhanced ultrasound is nearly as effective as computed tomographic angiography (CTA) for detecting endoleaks in patients…

Wednesday, May 23, 2012 | Source: Archives of Internal Medicine

Stress Echo Appears Overused in Asymptomatic Patients after Revascularization

By Kim Dalton

After revascularization, stress echocardiography can help identify high risk asymptomatic patients, but it provides no better guidance for patient…

Tuesday, May 22, 2012 | Source: EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

By Caitlin E. Cox

PARIS, France—Findings on novel devices and imaging techniques, as well as other practice changing results, were presented at last week's EuroPCR 2012,…

Tuesday, May 22, 2012 | Source: Journal of the American College of Cardiology

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

By L.A. McKeown

Patients’ CYP2C19 genotype plays a significant role in responsiveness to clopidogrel in both the acute and maintenance phases of antiplatelet therapy,…

Monday, May 21, 2012 | Source: Circulation

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

By Kim Dalton

Drug eluting stents (DES) substantially reduce target vessel revascularization (TVR) following percutaneous coronary intervention (PCI) compared with…

Friday, May 18, 2012 | Source: EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

By Caitlin E. Cox

PARIS, France—Two large randomized trials presented May 17 at EuroPCR 2012 showed nearly identical results for biodegradeable polymer drug eluting…

Friday, May 18, 2012 | Source: EuroPCR 2012

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

By Jason Kahn

PARIS, France—Results from 2 observational studies presented May 15 at EuroPCR are consistent with a growing body of literature demonstrating improved…

Friday, May 18, 2012 | Source: EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

By Caitlin E. Cox
PARIS, France—New data from the SOURCE XT registry show that a second generation transcatheter aortic valve replacement (TAVR) device achieves the highest…

TCTMD Poll

What is the biggest clinical need for next generation DES (compared to current DES)?